The Net Margin of Carna Biosciences Inc (4572.T) is -342.42%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -342.42% |
| 2023-12-31 | -70.91% |
| 2022-12-31 | -97.32% |
| 2021-12-31 | -26.49% |
| 2020-12-31 | -98.03% |
| 2019-12-31 | 25.82% |
| 2018-12-31 | -160.41% |
| 2017-12-31 | -112.13% |
| 2016-12-31 | -35.72% |
| 2015-12-31 | 29.08% |